TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/15/24 20:38 | 2/9/24 | MGX | Metagenomi, Inc. | Health | BioPrd | Biological Products, (No Diag | Novo Holdings A/s | G7 | T | P.dm | 13,025 | 14.47 | 0 | 900 | 107 | 1,739 | D | ||||||||||||||||
8/11/23 16:31 | 8/9/23 | IOBT | Io Biotech, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | P.d | 5,000 | 2.03 | 0 | 2,469 | 76 | 5,707 | D | |||||||||||||||
2/21/23 16:19 | 2/16/23 | SPRB | Spruce Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | P.d | 6,999 | 3.17 | 0 | 2,208 | 49 | 6,722 | D | |||||||||||||||
9/16/22 14:35 | 9/14/22 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Novo Holdings A/s | G7 | T | P | 5,000 | 10.32 | 0 | 484 | 9 | 6,072 | D | |||||||||||||||
2/9/22 17:42 | 2/8/22 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Novo Holdings A/s | G7 | T | P.d | 12,500 | 15.00 | 0 | 833 | 26 | 4,017 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |